BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10874863)

  • 1. [Good clinical practice:impediment of source of progress?].
    Dormont J
    Rev Prat; 2000 Apr; 50(8):856-61. PubMed ID: 10874863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Organisation of clinical research in France: the new missions of inter-regional delegations for clinical research].
    Jaillon P
    Bull Acad Natl Med; 2008 May; 192(5):929-37; discussion 937-9. PubMed ID: 19238783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biomedical research: to know the judicial and legal aspects].
    Malavaud B
    Prog Urol; 1994 Apr; 4(2):181-4. PubMed ID: 8199625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress and problems for randomized clinical trials: from streptomycin to the era of megatrials.
    Hilbrich L; Sleight P
    Eur Heart J; 2006 Sep; 27(18):2158-64. PubMed ID: 16870690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Doctor-initiated clinical trials and the revised pharmaceutical affairs law].
    Takano T; Saijo N
    Gan To Kagaku Ryoho; 2003 Oct; 30(10):1391-7. PubMed ID: 14584270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Difficulties with conducting clinical trials in France].
    Zannad F; Plétan Y
    Therapie; 2001; 56(4):341-7. PubMed ID: 11677850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quality assurance in clinical studies: a necessity].
    Boll M; Binder J; Siegel A; Grundmann R
    Z Exp Chir Transplant Kunstliche Organe; 1990; 23(2):65-72. PubMed ID: 2278157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Opinion of the French National Academy of Medicine on the legislative framework for the application of the European Directive on biomedical research in humans].
    Rouëssé J
    Bull Acad Natl Med; 2003; 187(5):1001-15. PubMed ID: 14979061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Research in psychiatry and legislative restrictions].
    Bougerol T
    Encephale; 1996 May; 22 Spec No 1():63-8. PubMed ID: 8767029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmaceutical companies as sponsors of clinical trials--advantages and limitations].
    Reis LL
    Rev Port Cardiol; 1992 Apr; 11(4):333-8. PubMed ID: 1632988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ethics committees bear a responsibility for patient information. Informed consent implies that the patient understands what he has consented to].
    Werkö L
    Lakartidningen; 2002 Mar; 99(14):1552-5. PubMed ID: 12025208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic trial, clinical research and therapeutic freedom--medical aspects].
    Loew D
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):691-5. PubMed ID: 9527470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recommendation for studies of optimizing therapy protocols].
    Creutzig U; Winkler K
    Klin Padiatr; 1994; 206(4):191-3. PubMed ID: 7967415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reporting of informed consent, standard of care and post-trial obligations in global randomized intervention trials: a systematic survey of registered trials.
    Cohen ER; O'Neill JM; Joffres M; Upshur RE; Mills E
    Dev World Bioeth; 2009 Aug; 9(2):74-80. PubMed ID: 18445072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of medicines for children in Europe: ethical implications.
    Saint Raymond A; Brasseur D
    Paediatr Respir Rev; 2005 Mar; 6(1):45-51. PubMed ID: 15698816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experiences with GCP in the pharmaceutical industry [corrected].
    Rämsch KD
    Methods Find Exp Clin Pharmacol; 1993 May; 15(4):237-40. PubMed ID: 8240533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.